ANNX Form 4: Director William Carson Buys 4,115 Shares at $2.09
William H. Carson, a director of Annexon, Inc. (ANNX), purchased 4,115 shares of the company's common stock on 09/02/2025 at a weighted average price of $2.09 per share.
Rhea-AI Filing Summary
William H. Carson, a director of Annexon, Inc. (ANNX), purchased 4,115 shares of the company's common stock on 09/02/2025 at a weighted average price of $2.09 per share. The shares were bought under a Rule 10b5-1 trading plan adopted March 17, 2025, through multiple trades priced between $2.06 and $2.115.
Following the transaction, the reporting person beneficially owned 37,945 shares. The filing reports the purchase as a planned, rule-compliant acquisition rather than an opportunistic trade.
Positive
- Purchase executed under a Rule 10b5-1 trading plan, which indicates pre-scheduled, compliant insider trading
- Director increased beneficial ownership to 37,945 shares, aligning insider holdings with shareholder interests
- Price transparency provided: weighted average $2.09 and trade price range $2.06–$2.115 disclosed
Negative
- None.
Insights
TL;DR: Director bought a small block of stock under a 10b5-1 plan; increases insider stake modestly.
The 4,115-share purchase at a weighted average of $2.09 represents a routine, planned acquisition under a 10b5-1 program adopted March 17, 2025. The transaction increases the director's beneficial ownership to 37,945 shares. Given the size and the planned nature, the trade is unlikely to be materially price-moving or indicative of unexpected private information. Investors typically view 10b5-1 purchases as orderly and preplanned.
TL;DR: Use of a 10b5-1 plan demonstrates governance compliance but limits real-time signaling value.
The filing clearly states the purchases were executed pursuant to a Rule 10b5-1 plan, which strengthens procedural compliance and reduces insider trading concerns. Because the trades were executed across a range of prices and under a pre-established plan, the information provides limited insight into management's current private view of corporate prospects. The disclosure is transparent and meets Section 16 reporting requirements.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock | 4,115 | $2.09 | $9K |
Footnotes (2)
- F1. The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted March 17, 2025.
- F2. This transaction was executed in multiple trades in prices ranging from $2.06 to $2.115, inclusive. The price reported in Column 4 above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each respective price within the range set forth in this footnote.
FAQ
What transaction did ANNX director William H. Carson report on Form 4?
Was the purchase part of a 10b5-1 plan for ANNX insider trades?
Does this Form 4 indicate any sales or derivative transactions for ANNX?
AI-generated analysis. How Rhea-AI works. Not financial advice.